Transfusion associated graft versus host disease

Indian Pediatrics

Volumn 41, Issue 12, 2004, Pages 1260-1264

  Gupta, Anju ^a   Bansal, Deepak ^a   Dass, Rashna ^a   Das, Ashim ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Graft versus host disease; Transfusion

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BILIRUBIN; CEFOTAXIME; CYCLOSPORIN; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; METHYLPREDNISOLONE; PREDNISOLONE; THROMBOCYTE CONCENTRATE; THYMOCYTE ANTIBODY; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANEMIA; APLASTIC ANEMIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD TRANSFUSION REACTION; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ERYTHROCYTE TRANSFUSION; FEBRILE NEUTROPENIA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IRRADIATION; MALE; MEDICAL EXAMINATION; PRESCHOOL CHILD; SKIN BIOPSY; THROMBOCYTE TRANSFUSION;

BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHYLPREDNISOLONE;

EID: 11944260162     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Webb IJ, Anderson KC. Transfusion-associated graft-versus-host disease. In: Scientific Basis of Transfusion Medicine: Implications for Clinical Practice. 2nd Edition. Anderson KC, Ness PM, editors. Philadelphia: WB Saunders Company; 2000. p 420-426.
2. Mathe G, Bernard J, Schwarzenberg L, Larrieu MJ, Ialanne CM, Dutrix A, et al. Essai de traitement de sujets atteints de leucemie aigue en remission par irradiation totale suivie de transfusion de moelle osseuse homologue. Revues Francaises d'Etudes Clinique et Biologique 1959; 4: 657-704.
3. Burdick JF, Vogelsang GB, Smith WJ, Farmer ER, Bias WB, Kaufmann SH, et al. Severe graft-versus-host disease in a liver transplant recipient. N Engl J Med 1988; 318: 689-691.
4. Decoste SD, Boudreaux C, Dover JS. Transfusion-associated graft-versus-host disease in patients with malignancies: report of two cases and the review of literature. Arch Dermatol 1990; 126: 1324-1329.
5. Grogan TM, Broughton DD, Doyle WF. Graft-versus-host reaction (GVHR): a case report suggesting GVHR occurred as a result of maternofetal cell transfer. Arch Pathol 1975; 99: 330-334.
6. Schroeder ML. Transfusion-associated graft-versus-host disease. Br J Hematol 2002; 117: 275-287.
7. Shimoda T. On postoperative erythroderma (In Japanese). Geka 1955; 17: 487-492.
8. Pinkerton CR, Bowman A, Holtzel H, Chessells JM. Intensive consolidation chemotherapy for acute lymphoblastic leukemia (UKALL X pilot study). Arch Dis Child 1987; 62: 12-18.
9. Marwaha RK, Bansal D, Trehan A, Varma N. Efficacy of cyclosporine monotherapy in childhood apalstic anemia. Indian J Hemat & Blood Tran 2001; 19: 106-108.
10. Jindal B, Narang A, Das R. Post-transfusion graft-versus-host disease-an undercognized entity. Indian Pediatr 2001; 38: 179-183.
11. Wagner FF, Flegel WA. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion 1995; 35: 284-291.
12. Ohto H, Anderson KC. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfusion Med Rev 1996; 10: 31-43.
13. Yasukawa M, Shinozaki F, hato T, Takada K, Ishii Y, Tamai T, et al. Successful treatment of transfusion-associated graft-versus-host disease. Br J Hematol 1994; 86: 831-836.
14. Prince M, Szer J, van der Weyden MB, Pedersen JS, Holdsworth RF, Whyte G. Transfusion-associated graft-versus-host disease after cardiac surgery: response to antihymocyteglobulin and corticosteroid therapy. NZ J Med 1991; 21: 43-46.